NEFL and Parkinson disease: We set out to determine whether the levels of serum NfL (1) exhibit differences between patients with cognitively normal PD (PD-CN) and those without PD (normal controls, NC), (2) increase as PD advances, and (3) have the ability to predict long-term cognitive deterioration in individuals with PD.